By Josh White
Date: Tuesday 05 May 2026
(Sharecast News) - Pfizer reported stronger-than-expected first-quarter results on Tuesday and reaffirmed its full-year guidance, as growth from older blockbusters and recently launched or acquired medicines offset another sharp fall in Covid product sales.
| Patent Woes Threaten Drug Firms | 07-Mar-2011 | New York Times |
| Stocks push higher on deals and strong earnings | 09-Feb-2011 | USA Today |
| Dow soars to close above 12,000 | 02-Feb-2011 | Wall Street Journal |
| Pfizer To Close UK Plant And Axe 2,400 Jobs | 01-Feb-2011 | Sky News |
| Despite good earnings reports, stocks tumble | 21-Oct-2009 | Wall Street Journal |
| Currency | US Dollars |
| Share Price | $ 26.31 |
| Change Today | $ -0.31 |
| % Change | -1.16 % |
| 52 Week High | $28.55 |
| 52 Week Low | $23.60 |
| Volume | 32,591,426 |
| Shares Issued | 5,686m |
| Market Cap | $149,599m |
| RiskGrade | 102 |
| Time | Volume / Share Price |
| 16:01 | 3,347,005 @ $26.31 |
| 15:59 | 119 @ $26.31 |
| 15:59 | 100 @ $26.31 |
| 15:59 | 100 @ $26.31 |
| 15:59 | 516 @ $26.31 |
You are here: research